42: Biosimilars; What, How, When?
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
42: Biosimilars; What, How, When?
-
Narrated by:
-
By:
About this listen
Please join your host, Justin Baker, as he learns from industry experts, Connor Nell and Brian Biehn, why biosimilars are becoming such an eye-opening opportunity, and why independents need to take a hard look at them.
In addition to being an alternative to expensive brand name drugs, the breadth of biosimilars is growing exponentially, and gaining acceptance with physicians, pharmacists and patients.
This countertop chat dives deeply into increasing access, understanding their benefits, and gaining confidence in these emerging therapies.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.